Skip to content

A Transdiagnostic Internet Intervention for Parents of Children With Anxiety and Depressive Symptoms

Digital Parent-led Transdiagnostic Interventions for Child and Adolescent Anxiety and Depressive Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05341297
Acronym
ParentKIT
Enrollment
111
Registered
2022-04-22
Start date
2022-03-01
Completion date
2023-08-31
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Emotional Problem, Psychological Distress

Keywords

Internet intervention, transdiagnostic, parent-led intervention, internalizing problems, children, Rational emotive and behavioral therapy

Brief summary

The purpose of this study is to evaluate the efficacy of a transdiagnostic, parent-led, Internet-delivered intervention in reducing child and adolescent internalizing problems.

Detailed description

Anxiety and depressive symptoms are common in children and adolescents. There is substantial research indicating that transdiagnostic Internet interventions are effective for adults and children with anxiety and depressive disorders; however, there is limited research on the efficacy of such programs aimed at parents of children and adolescents with anxiety and depressive symptoms. This study aims to investigate the efficacy of a transdiagnostic Internet intervention for parents of children with elevated anxiety and depressive symptoms.

Interventions

BEHAVIORALParentKIT

The intervention is structured in 9 modules through which parents learn to identify and manage their children's anxiety and depressive symptoms. The Internet intervention is guided by two psychotherapists under supervision training in Cognitive Behavioral Therapy, trained by the first author on the treatment protocol.

Sponsors

Babes-Bolyai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* parent of a child/ adolescent aged 6 to 14 years * elevated internalizing problems * have Internet access

Exclusion criteria

* undergoing psychotherapy/ pharmacological treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in the brief Revised Children's Anxiety and Depression Scale - parent versionBaseline, 3 weeks and follow-up at 1 month after treatment terminationMeasure of child anxiety and depressive symptoms, as reported by parents. Scores range between 0 and 33; higher scores indicate higher anxiety and depressive symptoms.

Secondary

MeasureTime frameDescription
Change in the Patient Health Questionnaire-4Baseline, 3 weeks and follow-up at 1 month after treatment terminationMeasure of anxiety and depressive symptoms - will be used to measure changes in parental distress. Scores range between 0 and 12. Higher scores indicate higher distress.
Change in the Parental Self-Efficacy ScaleBaseline, 3 weeks and follow-up at 1 month after treatment terminationMeasure of parental self-efficacy in relationship to parenting practices that may decrease anxiety and depression risks for adolescents. Total scores range between and 9 and 36. Higher scores indicate higher parental self-efficacy.
Change in the Family Accommodation ScaleBaseline, 3 weeks and follow-up at 1 month after treatment terminationMeasure of parental anxiety accommodations. Scores range between 0 and 52. Higher scores indicate higher parental anxiety accommodations.
Satisfaction with the intervention3 weeks after treatment initiationClient satisfaction will be measured with Client Satisfaction Questionnaire, short form (Attkisson & Zwick, 1982). Scores range from 8 to 32, with higher scores indicating greater satisfaction with the intervention.

Countries

Romania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026